174 related articles for article (PubMed ID: 36171169)
1. Robotic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: Analysis of surgical outcomes and long-term prognosis in a high-volume center.
Zhang XP; Xu S; Zhao ZM; Liu Q; Zhao GD; Hu MG; Tan XL; Liu R
Hepatobiliary Pancreat Dis Int; 2023 Apr; 22(2):140-146. PubMed ID: 36171169
[TBL] [Abstract][Full Text] [Related]
2. A novel online calculator to predict early recurrence and long-term survival of patients with resectable pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: A multicenter study.
Zhang XP; Gao YX; Xu S; Zhao GD; Hu MG; Tan XL; Zhao ZM; Liu R
Int J Surg; 2022 Oct; 106():106891. PubMed ID: 36165934
[TBL] [Abstract][Full Text] [Related]
3. Outcomes in patients with pancreatic ductal adenocarcinoma (PDAC) undergoing robotic (RPD) or open pancreaticoduodenectomies (OPD): a propensity score-weighted survival analysis.
Mejia A; Shah J; Vivian E; Beard R; Acharya P; Gutierrez JCB
J Robot Surg; 2023 Jun; 17(3):1085-1096. PubMed ID: 36581740
[TBL] [Abstract][Full Text] [Related]
4. Preoperative maximum standardized uptake value and carbohydrate antigen 19-9 were independent predictors of pathological stages and overall survival in Chinese patients with pancreatic duct adenocarcinoma.
Gu X; Zhou R; Li C; Liu R; Zhao Z; Gao Y; Xu Y
BMC Cancer; 2019 May; 19(1):456. PubMed ID: 31092213
[TBL] [Abstract][Full Text] [Related]
5. Derivation and validation of a preoperative prognostic model for resectable pancreatic ductal adenocarcinoma.
Xu S; Zhang XP; Zhao GD; Zou WB; Zhao ZM; Liu Q; Hu MG; Liu R
Hepatobiliary Pancreat Dis Int; 2023 Apr; 22(2):160-168. PubMed ID: 36171167
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Nomogram for Patients With Pancreatic Ductal Adenocarcinoma of Pancreatic Head After Pancreaticoduodenectomy.
Zhuang H; Zhou Z; Ma Z; Huang S; Gong Y; Li Z; Liu C; Wang S; Chen B; Zhang C; Hou B
Clin Med Insights Oncol; 2021; 15():11795549211024149. PubMed ID: 34211308
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Nomogram for patients undergoing radical Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head.
Wu C; Hou SZ; Wu Z; Huang X; Wang Z; Tian B
BMC Cancer; 2021 May; 21(1):624. PubMed ID: 34044806
[TBL] [Abstract][Full Text] [Related]
8. A nomogram based on preoperative inflammatory markers predicting the overall survival of pancreatic ductal adenocarcinoma.
Xu J; Shi KQ; Chen BC; Huang ZP; Lu FY; Zhou MT
J Gastroenterol Hepatol; 2017 Jul; 32(7):1394-1402. PubMed ID: 27973703
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the prognostic impact of pre- and post-operative CA19-9, SPan-1, and DUPAN-II levels in patients with pancreatic carcinoma.
Kondo N; Murakami Y; Uemura K; Nakagawa N; Takahashi S; Ohge H; Sueda T
Pancreatology; 2017; 17(1):95-102. PubMed ID: 27746094
[TBL] [Abstract][Full Text] [Related]
10. Preoperative prediction of disease-free survival in pancreatic ductal adenocarcinoma patients after R0 resection using contrast-enhanced CT and CA19-9.
Li D; Peng Q; Wang L; Cai W; Liang M; Liu S; Ma X; Zhao X
Eur Radiol; 2024 Jan; 34(1):509-524. PubMed ID: 37507611
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of preoperative prognostic factors in patients with resectable pancreatic ductal adenocarcinoma.
Izumo W; Higuchi R; Furukawa T; Yazawa T; Uemura S; Shiihara M; Yamamoto M
Scand J Gastroenterol; 2019 Jun; 54(6):780-786. PubMed ID: 31180790
[No Abstract] [Full Text] [Related]
12. Prognostic significance of preoperative PNI and CA19-9 for pancreatic ductal adenocarcinoma: A multi-institutional retrospective study.
Itoh S; Tsujita E; Fukuzawa K; Sugimachi K; Iguchi T; Ninomiya M; Maeda T; Kajiyama K; Adachi E; Uchiyama H; Utsunomiya T; Ikeda Y; Maekawa S; Toshima T; Harada N; Yoshizumi T; Mori M
Pancreatology; 2021 Oct; 21(7):1356-1363. PubMed ID: 34426076
[TBL] [Abstract][Full Text] [Related]
13. A Prognostic Nomogram for Disease-Specific Survival in Patients with Pancreatic Ductal Adenocarcinoma of the Head of the Pancreas Following Pancreaticoduodenectomy.
Li HB; Zhou J; Zhao FQ
Med Sci Monit; 2018 Sep; 24():6313-6321. PubMed ID: 30198517
[TBL] [Abstract][Full Text] [Related]
14. Robotic versus open pancreatoduodenectomy in patients with pancreatic duct adenocarcinoma after the learning curve: a propensity score-matched analysis.
Chen H; Weng Y; Zhao S; Wang W; Ji Y; Peng C; Deng X; Shen B
Surg Endosc; 2024 Feb; 38(2):821-829. PubMed ID: 38066192
[TBL] [Abstract][Full Text] [Related]
15. Oncological outcomes of robotic-assisted versus open pancreatoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score-matched analysis.
Weng Y; Jiang Y; Fu N; Jin J; Shi Y; Huo Z; Deng X; Peng C; Shen B
Surg Endosc; 2021 Jul; 35(7):3437-3448. PubMed ID: 32696148
[TBL] [Abstract][Full Text] [Related]
16. Robotic approach mitigates the effect of major complications on survival after pancreaticoduodenectomy for periampullary cancer.
Meyyappan T; Wilson GC; Zeh HJ; Hogg ME; Lee KK; Zureikat AH; Paniccia A
Surg Endosc; 2023 Feb; 37(2):1181-1187. PubMed ID: 36163566
[TBL] [Abstract][Full Text] [Related]
17. Long-term oncologic outcomes of robotic and open pancreatectomy in a national cohort of pancreatic adenocarcinoma.
Nassour I; Winters SB; Hoehn R; Tohme S; Adam MA; Bartlett DL; Lee KK; Paniccia A; Zureikat AH
J Surg Oncol; 2020 Aug; 122(2):234-242. PubMed ID: 32350882
[TBL] [Abstract][Full Text] [Related]
18. A Multi-institutional Comparison of Perioperative Outcomes of Robotic and Open Pancreaticoduodenectomy.
Zureikat AH; Postlewait LM; Liu Y; Gillespie TW; Weber SM; Abbott DE; Ahmad SA; Maithel SK; Hogg ME; Zenati M; Cho CS; Salem A; Xia B; Steve J; Nguyen TK; Keshava HB; Chalikonda S; Walsh RM; Talamonti MS; Stocker SJ; Bentrem DJ; Lumpkin S; Kim HJ; Zeh HJ; Kooby DA
Ann Surg; 2016 Oct; 264(4):640-9. PubMed ID: 27433907
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.
Maire F; Hammel P; Terris B; Paye F; Scoazec JY; Cellier C; Barthet M; O'Toole D; Rufat P; Partensky C; Cuillerier E; Lévy P; Belghiti J; Ruszniewski P
Gut; 2002 Nov; 51(5):717-22. PubMed ID: 12377813
[TBL] [Abstract][Full Text] [Related]
20. Ratio of CA19-9 Level to Total Tumor Volume as a Prognostic Predictor of Pancreatic Carcinoma After Curative Resection.
Xu J; Lyu S; Zhao Y; Zhang X; Liu Z; Zhao X; He Q
Technol Cancer Res Treat; 2022; 21():15330338221078438. PubMed ID: 35138217
[No Abstract] [Full Text] [Related]
[Next] [New Search]
